Supernus to Present at Two November Healthcare Conferences
Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that Jack Khattar
ROCKVILLE, Md., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that Jack Khattar, President and CEO of Supernus Pharmaceuticals, will present a Company overview and update, as well as host investor meetings, at the following November conferences:
Stifel 2022 Healthcare Conference
Date: Tuesday, November 15, 2022
Time: 8:00 a.m. ET
Place: Lotte New York Palace Hotel, New York
13th Annual Jefferies London Healthcare Conference
Date: Thursday, November 17, 2022
Time: 9:05 a.m. ET / 2:05 p.m. GMT
Place: Waldorf Hilton, London, UK
Investors interested in arranging a meeting with the Company's management during these conferences should contact the respective conference coordinators.
